Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Allergien
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Dänemark
  • Deutschland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kroatien
  • Litauen
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Asien / Pazifik
  • China
  • Hong Kong
  • Indonesien
  • Japan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Datamonitor
  • Euromonitor
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Cough, Cold and Allergy (Hay Fever) Remedies in Spain

Euromonitor

Euromonitor

5 / 2012
36 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Spanien
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

675,00 €*
PDF-Datei per E-Mail , versandkostenfrei


The virulence of influenza outbreaks — typically one in autumn and another in winter - in 2010 were not significantly different from other years and hence cough and cold sales evolved inline with previous years. During 2010, around 90% of the flu cases were 'Gripe A”. Sales of cough, cold and allergy (hay fever) remedies reached EUR388 million.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SPAIN

Euromonitor International

May 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011

Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011

Table 3 Sales of Decongestants by Category: Value 2006-2011

Table 4 Sales of Decongestants by Category: % Value Growth 2006-2011

Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011

Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011

Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011

Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011

Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016

Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Bayer Hispania SA in Consumer Health (spain)

Strategic Direction

Key Facts

Summary 1 Bayer Hispania SA: Key Facts

Company Background

Production

Competitive Positioning

Summary 2 Bayer Hispania SA: Competitive Position 2011

Boehringer Ingelheim España SA in Consumer Health (spain)

Strategic Direction

Key Facts

Summary 3 Boehringer Ingelheim España SA: Key Facts

Summary 4 Boehringer Ingelheim España SA: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 5 Boehringer Ingelheim España SA: Competitive Position 2011

Mcneil Iberica Slu in Consumer Health (spain)

Strategic Direction

Key Facts

Summary 6 McNeil Iberica SLU: Key Facts

Company Background

Production

Competitive Positioning

Summary 7 McNeil Iberica SLU: Competitive Position 2011

Novartis Farmaceutica SA in Consumer Health (spain)

Strategic Direction

Key Facts

Summary 8 Novartis Farmaceutica SA: Key Facts

Company Background

Production

Competitive Positioning

Summary 9 Novartis Consumer Health SA: Competitive Position 2011

Uriach-aquilea OTC Sl in Consumer Health (spain)

Strategic Direction

Key Facts

Summary 10 Uriach-Aquilea OTC SL: Key Facts

Summary 11 Uriach-Aquilea OTC SL: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 12 Uriach-Aquilea OTC SL: Competitive Position 2011

Executive Summary

Economy Fears A New Recession

New Laws in the Pipeline

Mcneil Retains Leadership of Consumer Health

Grocery Retailers Consolidate Trends

Slow Movement Going Forward

Key Trends and Developments

Economy Fears A New Recession

New Laws in the Pipeline

Climate Shapes Sales

Spanish Population

the Silent Pandemic

Market Indicators

Table 11 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 12 Life Expectancy at Birth 2006-2011

Market Data

Table 13 Sales of Consumer Health by Category: Value 2006-2011

Table 14 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 15 Consumer Health Company Shares 2007-2011

Table 16 Consumer Health Brand Shares 2008-2011

Table 17 Penetration of Private Label by Category 2006-2011

Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 20 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Consumer Health Registration and Classification

Advertising

Packaging and Labelling

Waste

Distribution

Groups and Associations for Pharmacists Grow

De-listing Or De-reimbursement

Vitamins and Dietary Supplements Registration and Classification

Retail Distribution

Alternative Therapy

Homoeopathic Medicines

Self-medication/self-care and Preventative Medicine

Switches

Definitions

Sources

Summary 13 Research Sources

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: